QA: ARATANA THERAPEUTICS INC. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509190_2017_ARATANA_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509190')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001509190, ARATANA THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 101,542,000
1 IntangibleAssetsNetIncludingGoodwill 47,021,000
2 PropertyPlantAndEquipmentNet 1,948,000
3 remainder_Assets 895,000
4 LiabilitiesCurrent 34,688,000
5 LiabilitiesNoncurrent 540,000
6 remainder_Liabilities 25,775,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 27,342,000
9 ResearchAndDevelopmentExpense 30,462,000
10 remainder_Expenses 11,566,000
11 remainder_Revenues 38,551,000
12 remainder_NetIncome -2,756,000
13 remainder_ComprehensiveNetIncome -542,000
  yvar yval
0 Assets 151,406,000
1 Liabilities 61,003,000
2 Expenses 69,370,000
3 Revenues 38,551,000
4 StockholdersEquity 90,403,000
5 NetIncome -33,575,000
6 ComprehensiveNetIncome -33,846,000
7 BaseVar 161,814,000
8 EconomicCapitalRatio 1.15

Edgar->Model Mapping

Feature Distribution